ArticlePloS one2025
Prevalence and genotype distribution of Human Papillomavirus (HPV) among 14,110 women in Anqing urban area: A population-based cross-sectional survey.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human papillomavirus (HPV), particularly persistent infection with high-risk types, is one of the major etiological factors for cervical cancer, posing significan health risks to women. This study aims to analyze the epidemiology of HPV infection among women in the Anqing region, and provide a valuable reference for the prevention and control strategies of cervical cancer in this region. Between 2022 and 2024, a total of 14,110 women attending the First People's Hospital of Anqing were enrolled in this study. All participants underwent both HPV testing and ThinPrep cytology test (TCT). The overall prevalence of HPV infection in the study population was 18.97%. The predominant pattern of HPV infection identified was single infection, followed by double infection. The top five HPV genotypes detected were HPV 52 (2.78%), HPV 81 (1.55%), HPV 58 (1.42%), HPV 16 (1.20%) and HPV 53 (1.16%). The highest HPV positivity rate was observed in women aged < 20 years (79.17%), followed by those aged 50-59 (84.88%), and then those aged > 59 years (42.53%). Among all HPV-positive women, analysis of TCT results revealed that HPV 52, 53, 16, 58 and 81 were frequently detected in ASC-US, HPV 52, 16 and 58 in ASC-H, HPV 52, 58 and 81 in LSIL, and HPV 16, 58 and 18 were the most common genotypes in HSIL. HPV 52, 81, 58, 16 and 53 are the common genotypes among women in Anqing region. The highest prevalence rates of HPV infection were observed in women aged <20 years and those aged 50-59 years. Based on these findings, the 9-valent HPV vaccine is strongly recommended as a primary prevention strategy for this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.